Acetylon Pharmaceuticals Incorporated clinical trials
Acquired by Bristol-Myers Squibb, Nov 20, 2019 · source ↗
The registry lists 1 studies whose lead sponsor is Acetylon Pharmaceuticals Incorporated. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 11, 2014.
Before and after it joined Bristol-Myers Squibb
- First submitted before Acetylon Pharmaceuticals Incorporated became part of Bristol-Myers Squibb
- 1
- First submitted after Acetylon Pharmaceuticals Incorporated became part of Bristol-Myers Squibb
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Acetylon Pharmaceuticals Incorporated1 study
Something wrong with this grouping? Tell us on the Bristol-Myers Squibb page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Bristol-Myers Squibb studies →
- Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy SubjectsCompletedNCT02088398Phase 1
Sponsor listed in the registry: Acetylon Pharmaceuticals Incorporated · First submitted before Acetylon Pharmaceuticals Incorporated became part of Bristol-Myers Squibb